Sentinel lymph node assessment in breast cancer—an update on current recommendations
G Cserni, A Maguire, S Bianchi, A Ryska, A Kovács - Virchows Archiv, 2022 - Springer
Sentinel lymph node biopsy (SLNB) has become the preferred method of surgical
pathological nodal staging of early breast cancer by the end of the nineties. As the most …
pathological nodal staging of early breast cancer by the end of the nineties. As the most …
The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overview
JC Vázquez, A Piñero, FJ de Castro, A Lluch… - Clinical and …, 2022 - Springer
Purpose We conducted a systematic review to analyse the performance of the sentinel
lymph-node biopsy (SLNB) after the neoadjuvant chemotherapy, compared to axillary lymph …
lymph-node biopsy (SLNB) after the neoadjuvant chemotherapy, compared to axillary lymph …
[HTML][HTML] Pathology after neoadjuvant treatment–How to assess residual disease
While systemic therapy for non-metastatic, invasive breast cancer is provided to minimize
the risk of recurrence, neoadjuvant therapy (NAT) is given prior to surgery to downstage the …
the risk of recurrence, neoadjuvant therapy (NAT) is given prior to surgery to downstage the …
A rare case of invasive micropapillary carcinoma of the breast
Invasive micropapillary carcinoma (IMPC) is a rare, distinct histological subtype of breast
carcinoma. While micropapillary histological architecture is found in up to 2–8% of all breast …
carcinoma. While micropapillary histological architecture is found in up to 2–8% of all breast …
[HTML][HTML] Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast …
Neoadjuvant therapy (NAT) in breast cancer is administered to downstage the tumor, de-
escalate surgery, and provide prognostic information that can be used to tailor subsequent …
escalate surgery, and provide prognostic information that can be used to tailor subsequent …
Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study
H Fatayer, RL O'Connell, F Bannon… - British Journal of …, 2022 - academic.oup.com
Methods The NeST study protocol has been published previously 10. Briefly, this was a
prospective multicentre cohort study, including consecutive patients in participating units …
prospective multicentre cohort study, including consecutive patients in participating units …
Study on intraoperative localization of sentinel lymph nodes using freehand SPECT in breast cancer patients
Study on intraoperative localization of sentinel lymph nodes using freehand SPECT in
breast cancer patients Page 1 641 Videosurgery Creative Commons licenses: This is an …
breast cancer patients Page 1 641 Videosurgery Creative Commons licenses: This is an …
[PDF][PDF] 早期乳腺癌区域淋巴结局部处理
曹璐, 郑思悦, 陈佳艺 - 外科理论与实践, 2022 - qk.sjtu.edu.cn
早期乳腺癌区域淋巴结局部处理 Page 1 J Surg Concepts Pract 2022, Vol.27, No.5 !专家论坛!
早期乳腺癌区域淋巴结局部处理 曹潞, 郑思悦, 陈佳艺 (上海交通大学医学院附属瑞金医院放射 …
早期乳腺癌区域淋巴结局部处理 曹潞, 郑思悦, 陈佳艺 (上海交通大学医学院附属瑞金医院放射 …
Tratamiento neoadyuvante en el cáncer de mama. El papel del patólogo
O Burgués, L Terrádez, E Buch, MT Martínez… - Revista de Senología y …, 2022 - Elsevier
El tratamiento neoadyuvante es una práctica estándar en las pacientes con cáncer de
mama, que permite realizar cirugías más conservadoras, aporta información pronóstica …
mama, que permite realizar cirugías más conservadoras, aporta información pronóstica …
AGO-Empfehlungen zur operativen Therapie der Axilla nach neoadjuvanter Chemotherapie: Update 2021
M Friedrich, T Kühn, W Janni, V Müller… - Senologie-Zeitschrift …, 2022 - thieme-connect.com
Über viele Jahrzehnte war die komplette Ausräumung der axillären Lymphknoten im Sinne
einer Axilladissektion ein Standardverfahren in der Therapie des Mammakarzinom. Die …
einer Axilladissektion ein Standardverfahren in der Therapie des Mammakarzinom. Die …